International Pharma Supplies Analytical Samples for Biosimilar Development Unlicensed Medicines Supplies Comperator Sourcing for clinical trials

International Pharma Supplies

We supply prescription only and OTC products to authorized wholesalers, licensed importers and aid organisations – from anywhere in the EU with a focus on German products.

Analytical Samples for Biosimilar Development

We supply analytical samples for Biosimilar development from almost anywhere in the world – Multi-country, Multi-batch and Multi-expiry date approach.

Unlicensed Medicines Supplies

We supply prescription only and OTC products to companies that have specialized in unlicensed medicines supplies, government agencies, hospitals and pharmacies.

Comperator Sourcing for clinical trials

We source Comparator products from almost anywhere in the World and have direct access to many innovators and approved supply sources.

Comperator Sourcing
for clinical trials

Analytical Samples for Biosimilar Development

Unlicensed Medicines Supplies

International
Pharma Supplies

EUDRA GMDP DATABASE

GMDP Database showing Certificates, Licenses and Non-Compliance. EudraGMP is the database of the European Community of manufacturing authorisations and of certificates of good manufacturing practice. The ...

EC published QUESTIONS AND ANSWERS to the GOOD DISTRIBUTION PRACTICE FOR MEDICINAL PRODUCTS FOR HUMAN USE

The EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and Medicinal products – quality, safety and efficacy Has published additional information to the GDP 2013/C 343/01 GOOD ...

Medizone and PassionBio agree on closer cooperation

PassionBio’s provides drug development, regulatory and commercial solutions for biologics, biosimilar/-better or mAb programs. Our aim is to foster cross-frontier development of your biosimilar portfolio. We ...

New EU GDP Guidelines – Part II

The “Guidelines on Good Distribution Practice of Medicinal Products for Human Use” have been published 07.03.2013. But only a few months later the GDP had to be renewed. The new version 2013/C 343/01 ...

MabThera SC now approved in EU for patients with non-Hodgkin lymphoma

Roche announced today that the EU Committee for Medicinal Products for Human Use (CHMP) recommended that the European Commission approve MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for ...

Medizone supports “Wings for Life” Foundation

The driving forces behind Wings for Life are the two-time motocross world champion Heinz Kinigadner and the founder of Red Bull, Dietrich Mateschitz. In 2003, Kinigadner's son Hannes had a tragic accident at ...

Biocon-Mylan’s Biosimilar of Herceptin approved in India

Biocon, India’s largest listed biotechnology company, informed it had received marketing authorisation from the Drugs Controller General of India (DCGI) for its trastuzumab biosimilar, being developed ...

Apotex Canada received its first Biosimilar registration in Europe of Amgen’s blockbuster cancer treatment filgrastim!

Apotex's version of filgrastim received regulatory approval from the European Commission. Out-of-patent filgrastim, a biologic drug branded as Neupogen by Amgen and as Grastofil by Apotex, is used to boost ...

New EU GDP Guidelines of 07.03.2013 – Update 08.09.2013

The “Guidelines on Good Distribution Practice of Medicinal Products for Human Use” have been published 07.03.2013 and will apply across the European Union as of 8 September 2013. With the project ...

Celltrion files for approval of trastuzumab (Herceptin) biosimilar (CT-P6) in Korea

On June 4th Celltrion officially announced that it has filed for Ministry of Food and Drug Safety (MFDS, formerly the Korea Food and Drug Administration) approval of CT-P6 with same indications of the original ...
Pages:12»